For citations:

Chaulin A.M. New groups of hypolipidemic medications based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1. Clinical Medicine (Russian Journal). 2020;98(11-12):739-744. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-11-12-739-744